A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney diseaseSalim S. Hayek, Jochen Reiser, Morgan E. Grams et al.|Nature Medicine|2017Cited by 204
A high-content screen of FDA approved drugs to enhance CAR T cell function: ingenol-3-angelate improves B7-H3-CAR T cell activity by upregulating B7-H3 on the target cell surface via PKCα activationHa Won Lee, Christopher DeRenzo|Journal of Experimental & Clinical Cancer Research|2024Cited by 5